NASDAQ:TOI Oncology Institute (TOI) Stock Price, News & Analysis $0.51 +0.02 (+4.09%) (As of 07/5/2024 ET) Add Compare Share Share Today's Range$0.49▼$0.5550-Day Range$0.41▼$1.1652-Week Range$0.41▼$2.66Volume61,185 shsAverage Volume107,116 shsMarket Capitalization$37.85 millionP/E RatioN/ADividend YieldN/APrice Target$2.50 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Get Oncology Institute alerts: Email Address Oncology Institute MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside391.6% Upside$2.50 Price TargetShort InterestHealthy0.74% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthGrowingFrom ($0.63) to ($0.35) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.1.49 out of 5 starsMedical Sector647th out of 879 stocksOffices & Clinics Of Medical Doctors Industry6th out of 7 stocks 3.5 Analyst's Opinion Consensus RatingOncology Institute has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageOncology Institute has received no research coverage in the past 90 days.Read more about Oncology Institute's stock forecast and price target. Previous Next 3.0 Short Interest Percentage of Shares Shorted0.74% of the float of Oncology Institute has been sold short.Short Interest Ratio / Days to CoverOncology Institute has a short interest ratio ("days to cover") of 1.3, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Oncology Institute has recently increased by 13.19%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldOncology Institute does not currently pay a dividend.Dividend GrowthOncology Institute does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for TOI. Previous Next 0.6 News and Social Media Coverage Search InterestOnly 1 people have searched for TOI on MarketBeat in the last 30 days. This is a decrease of -75% compared to the previous 30 days.MarketBeat Follows2 people have added Oncology Institute to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Oncology Institute insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 9.50% of the stock of Oncology Institute is held by insiders.Percentage Held by InstitutionsOnly 36.86% of the stock of Oncology Institute is held by institutions.Read more about Oncology Institute's insider trading history. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Oncology Institute are expected to grow in the coming year, from ($0.63) to ($0.35) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Oncology Institute is -0.63, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Oncology Institute is -0.63, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioOncology Institute has a P/B Ratio of 0.66. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Oncology Institute's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Colonial MetalsCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.In answer to this issue, we have released a Special Report to the public. About Oncology Institute Stock (NASDAQ:TOI)The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.Read More TOI Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TOI Stock News HeadlinesMay 29, 2024 | globenewswire.comThe Oncology Institute to Participate at Upcoming Investor ConferencesMay 27, 2024 | msn.comKeep eye on neck swelling, doctors tell thyroid patientsJuly 7, 2024 | Wealthpin Pro (Ad)Trump’s Gift Could Unleash $51 Billion in New WealthIn January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.May 22, 2024 | globenewswire.comThe Oncology Institute Executives to Participate in Multiple Panel Presentations at APG 2024 Spring ConferenceMay 19, 2024 | msn.comThe Oncology Institute, Inc. (NASDAQ:TOI) Q1 2024 Earnings Call TranscriptMay 17, 2024 | msn.comResearchers discover new pathway to cancer cell death from chemotherapyMay 17, 2024 | msn.comBurjeel Medical City partners with TII for cancer treatmentMay 16, 2024 | cbsnews.comNew Sylvester Brain Tumor Institute offering personalized treatmentJuly 7, 2024 | Wealthpin Pro (Ad)Trump’s Gift Could Unleash $51 Billion in New WealthIn January 2021, Donald Trump silently rolled out a special gift to the American public… One that top house republicans called “The Key To America’s Economic Future”.May 15, 2024 | msn.comDoc develops treatment that puts his own brain cancer into remissionMay 15, 2024 | yahoo.comINSIGHT: Cancer Prevention and Research Institute of Texas (CPRIT) approved $51.8 million in grants to advance the state’s fight against cancerMay 15, 2024 | markets.businessinsider.comThe Oncology Institute, Inc. Reports Q1 Loss, Lags Revenue EstimatesMay 15, 2024 | finance.yahoo.comThe Oncology Institute Inc (TOI) (Q1 2024) Earnings Call Transcript Highlights: Navigating ...May 14, 2024 | msn.comEating this much sugar daily is safe as per ICMRMay 14, 2024 | investorplace.comTOI Stock Earnings: The Oncology Institute Misses EPS, Misses Revenue for Q1 2024May 14, 2024 | msn.comDoctor ‘brain cancer-free for a year’ after undergoing own breakthrough therapyMay 14, 2024 | globenewswire.comThe Oncology Institute Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 GuidanceMay 13, 2024 | msn.comOSF Healthcare collaboration hopes to improve lung cancer screening ratesSee More Headlines Receive TOI Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oncology Institute and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/14/2024Today7/07/2024Next Earnings (Estimated)8/13/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Offices & clinics of medical doctors Sub-IndustryN/A Current SymbolNASDAQ:TOI CUSIPN/A CIK1799191 Webtheoncologyinstitute.com Phone562-735-3226FaxN/AEmployees800Year FoundedN/APrice Target and Rating Average Stock Price Target$2.50 High Stock Price Target$2.50 Low Stock Price Target$2.50 Potential Upside/Downside+391.6%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($0.81) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-83,070,000.00 Net Margins-20.28% Pretax Margin-21.31% Return on Equity-109.10% Return on Assets-32.26% Debt Debt-to-Equity Ratio2.14 Current Ratio3.09 Quick Ratio2.83 Sales & Book Value Annual Sales$324.24 million Price / Sales0.12 Cash FlowN/A Price / Cash FlowN/A Book Value$0.77 per share Price / Book0.66Miscellaneous Outstanding Shares74,440,000Free Float67,366,000Market Cap$37.85 million OptionableNot Optionable Beta0.64 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key ExecutivesMr. Richard Alan Barasch (Age 70)Chairman of the Board Dr. Daniel Virnich FACHE (Age 45)M.D., MBA, Chief Executive Officer Comp: $614.62kMr. Mihir Arunkumar Shah CPA (Age 46)Chief Financial Officer Comp: $505.13kDr. Yale D. Podnos F.A.C.S. (Age 52)M.D., M.P.H., Chief Medical Officer Comp: $535.36kMr. Jeremy N. Castle M.B.A. (Age 40)Chief Operations Officer Mr. Mark Hueppelsheuser Esq.General CounselMr. Jordan McInerneyChief Development OfficerMore ExecutivesKey CompetitorsSHL TelemedicineNASDAQ:SHLTPono Capital TwoNASDAQ:PTWOCano HealthNYSE:CANOQConcord Medical ServicesNYSE:CCMHims & Hers HealthNYSE:HIMSView All CompetitorsInsiders & InstitutionsKent Lake Capital LLCBought 101,542 shares on 5/16/2024Ownership: 1.597%FourWorld Capital Management LLCBought 250,359 shares on 5/16/2024Ownership: 0.337%Element Pointe Advisors LLCSold 199,026 shares on 5/14/2024Ownership: 0.268%Nwam LLCBought 27,679 shares on 5/10/2024Ownership: 0.037%Quattro Financial Advisors LLCBought 55,960 shares on 4/18/2024Ownership: 0.075%View All Insider TransactionsView All Institutional Transactions TOI Stock Analysis - Frequently Asked Questions How have TOI shares performed this year? Oncology Institute's stock was trading at $2.04 at the beginning of 2024. Since then, TOI shares have decreased by 75.1% and is now trading at $0.5085. View the best growth stocks for 2024 here. How were Oncology Institute's earnings last quarter? The Oncology Institute, Inc. (NASDAQ:TOI) posted its quarterly earnings results on Tuesday, May, 14th. The company reported ($0.22) EPS for the quarter, missing analysts' consensus estimates of ($0.12) by $0.10. The company earned $94.67 million during the quarter, compared to the consensus estimate of $95.17 million. Oncology Institute had a negative net margin of 20.28% and a negative trailing twelve-month return on equity of 109.10%. How do I buy shares of Oncology Institute? Shares of TOI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:TOI) was last updated on 7/7/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…A megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored270x more lucrative than NVIDIA???If you've missed out on NVIDIA's recent 1,600% run... Don't worry. Because there's one AI stock that cou...Behind the Markets | SponsoredBiden to drop out; finish out his term?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | SponsoredExposed: 3 CENT Crypto to Explode June 24th?Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | SponsoredWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…Porter & Company | SponsoredObama’s DNC coupAs we approach the Democratic National Convention in August... many sense a Biden swap-out is looming. In f...Stansberry Research | SponsoredSHOCKING Crypto Leak…A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the ...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Oncology Institute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Institute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
